26.87
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$25.67
Offen:
$25.56
24-Stunden-Volumen:
1.40M
Relative Volume:
1.47
Marktkapitalisierung:
$1.24B
Einnahmen:
$203.27M
Nettoeinkommen (Verlust:
$-4.66M
KGV:
-268.70
EPS:
-0.1
Netto-Cashflow:
$3.47M
1W Leistung:
+14.10%
1M Leistung:
+53.63%
6M Leistung:
+135.81%
1J Leistung:
+105.11%
Axogen Inc Stock (AXGN) Company Profile
Firmenname
Axogen Inc
Sektor
Branche
Telefon
(386) 462-6817
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Vergleichen Sie AXGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
AXGN
Axogen Inc
|
26.87 | 1.18B | 203.27M | -4.66M | 3.47M | -0.10 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-17 | Eingeleitet | Lake Street | Buy |
| 2024-07-01 | Eingeleitet | Raymond James | Outperform |
| 2022-11-11 | Fortgesetzt | Jefferies | Buy |
| 2022-05-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Eingeleitet | Guggenheim | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-03-02 | Bestätigt | Lake Street | Buy |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Eingeleitet | Jefferies | Buy |
| 2017-11-21 | Bestätigt | Lake Street | Buy |
| 2017-07-31 | Eingeleitet | Leerink Partners | Outperform |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Eingeleitet | ROTH Capital | Buy |
| 2016-11-22 | Hochstufung | Lake Street | Hold → Buy |
| 2016-11-07 | Bestätigt | Wedbush | Outperform |
| 2016-11-03 | Herabstufung | Lake Street | Buy → Hold |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2014-05-14 | Eingeleitet | Dawson James | Buy |
| 2013-10-31 | Bestätigt | Ladenburg Thalmann | Buy |
Alle ansehen
Axogen Inc Aktie (AXGN) Neueste Nachrichten
Is SK International Export Limited a Hybrid Growth Value Stock Worth HoldingPrice-to-Book Ratio Updates & Free Tools to Monitor Market Corrections - earlytimes.in
First Week of July 2026 Options Trading For Axogen (AXGN) - Nasdaq
Is Axogen Inc. stock positioned for long term growth2025 Trading Volume Trends & AI Driven Stock Price Forecasts - newser.com
What analyst consensus says on Axogen Inc. stock2025 Volatility Report & Weekly High Momentum Picks - newser.com
How Axogen Inc. stock performs in weak economy2025 Breakouts & Breakdowns & Weekly Market Pulse Updates - newser.com
Is Axogen Inc. stock attractive after correction2025 Investor Takeaways & High Accuracy Swing Entry Alerts - newser.com
Can Axogen Inc. stock sustain institutional interest2025 Price Momentum & Short-Term Trading Alerts - newser.com
Axogen stock reaches 52-week high at 24.94 USD By Investing.com - Investing.com Nigeria
Axogen stock reaches 52-week high at 24.94 USD - Investing.com
Will Axogen Inc. stock deliver strong dividend growthJuly 2025 EndofMonth & Risk Controlled Daily Trade Plans - newser.com
Does Axogen Inc. show high probability of reboundSell Signal & Safe Entry Point Identification - newser.com
How risky is Axogen Inc. stock nowPortfolio Risk Report & Weekly Watchlist of Top Performers - newser.com
How supply chain issues affect Axogen Inc. stockJuly 2025 Analyst Calls & High Accuracy Swing Entry Alerts - newser.com
Axogen at Jefferies Conference: Strategic Growth in Nerve Repair By Investing.com - Investing.com Australia
Axogen at Jefferies Conference: Strategic Growth in Nerve Repair - Investing.com
Axogen (AXGN) Price Target Increased by 15.18% to 29.24 - Nasdaq
Technical analysis overview for Axogen Inc. stockWeekly Risk Report & Community Consensus Picks - newser.com
Is Axogen Inc. stock a buy for dividend growthPortfolio Gains Report & High Win Rate Trade Alerts - newser.com
Will Axogen Inc. stock gain from government policiesJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
What’s next for Axogen Inc. stock priceJuly 2025 Outlook & Weekly Return Optimization Alerts - newser.com
Is Axogen Inc. stock ready for a breakout2025 Fundamental Recap & High Accuracy Swing Trade Signals - newser.com
Why Axogen Inc. stock is a must watch in 2025Weekly Investment Summary & AI Powered Trade Plan Recommendations - newser.com
Multi factor analysis applied to Axogen Inc.2025 Market Trends & Low Risk High Win Rate Stock Picks - newser.com
Is Axogen Inc. stock a buy in volatile markets2025 AllTime Highs & Real-Time Chart Pattern Alerts - Fundação Cultural do Pará
Axogen Director William P. Burke Sells 22,818 Shares - TradingView
[Form 4] Axogen, Inc. Insider Trading Activity - Stock Titan
Volatility clustering patterns for Axogen Inc.2025 Momentum Check & Daily Price Action Insights - newser.com
Finanzdaten der Axogen Inc-Aktie (AXGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):